Email Updates

You are here

Home»Media

AVAC in the News

  • Six Injections a Year Could Stop New HIV Infections

    Six shots a year of an antiretroviral (ARV) drug can protect women from contracting HIV, new research shows. Activists say although the jab won’t be available immediately, countries need to start doing the planning—and the math—to introduce the bimonthly injection now.

    November 16, 2020
    PrEP
    Mail & Guardian

  • Study Finds Long-Acting Shot Helps Women Avoid HIV Infection

    Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily pills to help keep women from catching HIV from an infected sex partner.

    November 9, 2020
    PrEP
    Washington Post

  • The World Could See a COVID-19 Vaccine by Next Year — Here’s Who Will Get It and How

    Even if a jab is shown to work, there won’t be enough doses for everyone. Countries such as South Africa would need to make tough decisions about who it would give the vaccine to — and more importantly how to create a system to get it to them.

    October 14, 2020
    General
    Bhekisisa

  • Invest More in HIV Prevention, Experts Tell FG

    Experts have called on the federal government and other stakeholders to invest more in efforts to prevent HIV infection human immunodeficiency virus, HIV prevention interventions while advocating for supportive policy and programmes.

    October 13, 2020
    PrEP
    Vanguard

  • HIV/AIDS Prevention: NGOs Urge FG to Leverage Pop Culture to Reach Youths

    A coalition of NGOS on Monday urged the Federal Government to utilise diverse popular culture (pop culture) as avenues to create awareness and sensitise youths on HIV/AIDS prevention. The NGOs made the call during an online discussion on the role of media in HIV prevention advocacy’’, organised by the AVAC in collaboration with Journalists Against AIDS Nigeria (JAAIDS).

    October 6, 2020
    PrEP
    The Guardian Nigeria

  • Science, Not Politics, Must Lead to COVID Vaccine Approvals

    COVID-19 has devastated communities and health systems around the world — but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.

    September 30, 2020
    General
    POZ

  • Science, Not Politics, Must Lead to COVID Vaccine Approvals

    COVID-19 has devastated communities and health systems around the world – but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.

    September 24, 2020
    General
    Science Speaks

  • Standardized Metrics Can Reveal Region-Specific Opportunities in Community Engagement to Aid Recruitment in HIV Prevention Trials

    Standardized metrics and data collection aid meaningful comparisons of optimal community engagement methods for trial enrollment. Internet strategies had better success in the Americas/Switzerland than in sub-Saharan African countries. Data are essential in outreach staff efforts to improve screening-to-enrollment ratios.

    September 17, 2020
    General
    PLOS One

  • COVID Vaccines 101: Breaking Down the Good, the Bad, and the Promise of the Frontrunners

    With hundreds of potential COVID vaccine candidates being tested around the world, here’s a quick guide to which ones you should keep an eye on — and when we could see results.

    September 17, 2020
    General
    Bhekisisa

  • South Africa Is ‘Extremely Unlikely’ to Have COVID Vaccine Results Before Next Year

    One of South Africa’s three COVID-19 vaccine trials was recently put on hold after a participant in the United Kingdom developed an unexplained illness. After an independent review, AstraZeneca’s candidate, which was considered to be a frontrunner in the field, is expected to resume locally this week. But results are still a long shot for this year, says the trial’s lead investigator.

    September 15, 2020
    General
    Bhekisisa

Pages